BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Acetaminophen
,
rs2476601
,
SIRT1
,
Apoptosis
,
Breast Cancer
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
botulinum toxin type
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Botulinum neurotoxin A induced expression profiles in Raw264.7 cells
Tibialis anterior muscles after 1, 4, 12 and 52 weeks of botulinum toxin-A injection (BoNT-A)
Rho GTPases integrate control of cell structure and adhesion in keratinocytes
Neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative for 2wk or 2d
Explore Curated Studies Results
Literature
Most Relevant Literature
Botulinum toxin therapy: past, present and future developments.
Botulinum toxin in cancer therapy-current perspectives and limitations.
Review of Botulinum Toxin Uptake and Novel Theory Regarding Potential Spread Days After Injection.
Potency of botulinum toxin drugs: test systems and labelling.
Botulinum toxin in the management of parkinsonian disorders.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment
An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A
Effects of Botulinum Toxin Type A(Meditoxin®) on Sleep Bruxism
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ